Gene: LGR5
Official Full Name: leucine rich repeat containing G protein-coupled receptor 5provided by HGNC
Gene Summary: The protein encoded by this gene is a leucine-rich repeat-containing receptor (LGR) and member of the G protein-coupled, 7-transmembrane receptor (GPCR) superfamily. The encoded protein is a receptor for R-spondins and is involved in the canonical Wnt signaling pathway. This protein plays a role in the formation and maintenance of adult intestinal stem cells during postembryonic development. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11743 | LGR5 Knockout cell line (HeLa) | Human | LGR5 | 1:3~1:6 | Negative | Online Inquiry |
KO11744 | LGR5 Knockout cell line (HEK293) | Human | LGR5 | 1:3~1:6 | Negative | Online Inquiry |
LGR5 Gene Knockout Cell Lines are engineered cellular models specifically designed to study the implications of the LGR5 gene in various biological processes, including stem cell biology, cancer development, and cellular differentiation. By utilizing CRISPR-Cas9 gene-editing technology, these cell lines have been meticulously developed to exhibit complete loss-of-function of the LGR5 gene, enabling researchers to investigate its role with heightened precision.
Key functions of these cell lines lie in their ability to mimic the physiological responses of LGR5 in both stem cells and cancerous tissues, making them invaluable for elucidating the mechanistic pathways associated with stem cell maintenance and tumorigenesis. The knockout of LGR5 can influence various signaling pathways, including Wnt and Notch, which are crucial in cellular proliferation and differentiation. This capability allows for targeted studies and the development of therapeutic strategies that could manipulate these pathways for clinical benefit.
The scientific importance of LGR5 Gene Knockout Cell Lines extends beyond basic research; they are pivotal in drug discovery, toxicity testing, and personalized medicine initiatives. By enabling researchers to observe the phenotypic consequences of LGR5 loss, these models can facilitate the identification of potential biomarkers and therapeutic targets in diseases such as colorectal cancer and other LGR5-expressing malignancies.
What sets our LGR5 Gene Knockout Cell Lines apart are their high specificity, reproducibility, and ease of use in experimental setups, significantly reducing background noise and improving the clarity of results when compared to traditional knockout methods. Furthermore, our commitment to quality ensures that every batch of cell lines meets stringent performance standards, providing consistent and reliable data for experimental outcomes.
For researchers and clinicians seeking to unlock the complexities of LGR5's role in health and disease, our LGR5 Gene Knockout Cell Lines represent an essential tool in bridging the gap between discovery and therapeutic application. Driven by our extensive expertise in genetic engineering and a deep understanding of cellular mechanisms, we are dedicated to providing top-tier biological products that empower the scientific community to advance knowledge and innovation effectively.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.